Skip to main content

S. 4866

Referred to Committee

Sickle Cell Disease Treatment Centers Act of 2022

Introduced 9/15/2022•117th Congress•Senate

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

9/15/2022 • Senate

Summary

Sickle Cell Disease Treatment Centers Act of 2022

This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization.

Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.

Introduced in Senate • 9/15/2022

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

2
Democrats
0
Republicans
0
Independents

Sponsor

S[
Sen. Van Hollen, Chris [D-MD]

Democrat • MD

Sponsored 9/15/2022

Cosponsors (1)

S[
Sen. Booker, Cory A. [D-NJ]

D-NJ

Joined 9/15/2022

Bill Journey

Originated in the Senate

Introduced

September 15, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate9/15/2022

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors1